摘要 |
The invention relates to the novel products of formula (I): in which ---- represents a single or double bond; Ra represents H, Hal, alkoxy, O-cycloalkyl, heteroaryl, phenyl, NHCOalk, NHCOcycloalk or NR1R2; X represents S, SO or SO2; A represents NH or S; W represents H, alkyl or COR with R representing cycloalkyl; alkyl optionally substituted with NR3R4, alkoxy, hydroxyl, phenyl, heteroaryl or heterocycloalkyl; alkoxy optionally substituted with NR3R4, i.e. an O-(CH2)n-NR3R4 radical, an O-phenyl radical or an O-(CH2)n-phenyl radical, with phenyl optionally substituted and n= 1 to 4; or the NR1R2 radical; R1 represents H or alk and R2 represents H, cycloalkyl or alkyl; R3 and R4 represent H, alk, cycloalkyl, heteroaryl or phenyl; R1, R2 and/or R3, R4 form, with N, a ring optionally containing O, S, N and/or NH; all heterocycloalkyls, heteroaryls, phenyls and cyclic groups being optionally substituted; these products being in any of the isomer forms and the salts, as medicaments, especially as MET inhibitors |